Showing 1521-1530 of 1635 results for "".
- Second Sight Announces $2.4 Million, 4-Year Grant from NIH to Develop Spatial Localization and Mapping Technologyhttps://modernod.com/news/second-sight-announces-2-4-million-4-year-grant-from-nih-to-develop-spatial-localization-and-mapping-technology/2476926/Second Sight Medical Products announced receipt of a $2.4 million, 4-year grant from the National Institutes of Health (NIH) to develop spatial localization and mapping technology (SLAM). A joint collaboration with the Johns Hopkins University Applied Physics Laboratory (APL), the initiative is i
- Ocugen Announces Completion of its Merger with Histogenics to Create Ocular Gene Therapies and Biotherapeuticshttps://modernod.com/news/ocugen-announces-completion-of-its-merger-with-histogenics-to-create-ocular-gene-therapies-and-biotherapeutics/2476924/Ocugen announced the completion of its merger with Histogenics, and the change of the combined company’s name to “Ocugen, Inc.” Ocugen is expected to begin trading today on The Nasdaq Capital Market under the ticker symbol “OCGN.” The executive team of Ocugen has become the executive team of the
- Johnson & Johnson Vision Care Introduces Acuvue RevitaLens Multi-Purpose Disinfecting Solutionhttps://modernod.com/news/johnson-johnson-vision-care-introduces-acuvue-revitalens-multi-purpose-disinfecting-solution/2476925/Johnson & Johnson Vision has unveiled the first extension of the Acuvue brand name beyond contact lenses with the launch of Acuvue RevitaLens Multi-Purpose Disinfecting Solution (MPDS). Acuvue RevitaLens MPDS delivers disinfection and all-day comfort for reusable contact lens wearers. Its dua
- CooperVision Seeks Submissions for 2020 Best Practices Honoreeshttps://modernod.com/news/coopervision-seeks-submissions-for-2020-best-practices-honorees/2476909/Among thousands of eye care professionals at Vision Expo West in Las Vegas, CooperVision announced today its fifth annual search for the nation’s 2020 Best Practices (
- PECAA and Medical Eyeglass Center Announce Partnershiphttps://modernod.com/news/pecaa-and-medical-eyeglass-center-announce-partnership/2476885/PECAA, a nationwide Doctor Alliance Group currently serving over 3,700 independent eye care practitioners, announced that it has entered into a strategic partnership with Medical Eyeglass Center (MEC), an optical disp
- 2019 American Academy of Optometry Resident Travel Fellowship Recipients Announcedhttps://modernod.com/news/2019-american-academy-of-optometry-resident-travel-fellowship-recipients-announced/2476868/The American Academy of Optometry named the recipients of the 2019 Resident Travel Fellowship Awards. These travel fellowships will allow residents to attend Academy 2019 Orlando and 3rd World Congress of Optometry, October 23-27, 2019. Allergan Resident
- American Academy of Optometry Foundation Announces 2019 Fredric Rosemore Low Vision Educational Grant Recipienthttps://modernod.com/news/american-academy-of-optometry-foundation-announces-2019-fredric-rosemore-low-vision-educational-grant-recipient/2476860/The American Academy of Optometry Foundation (AAOF), in collaboration with the Fredric and Marion Rosemore Family Foundation, has announced that So-Yeon Sharon Lee, OD, FAAO, Dipl-ABO, was named the 2019 recipient of the Fredric Rosemore Low Vision Educational Grant. Dr. Lee is an Assistan
- The American Academy of Optometry Foundation Selects the 2019 Bert C. and Lydia M. Corwin Contact Lens Residency Award Recipienthttps://modernod.com/news/the-american-academy-of-optometry-foundation-selects-the-2019-bert-c-and-lydia-m-corwin-contact-lens-residency-award-recipient/2476831/The American Academy of Optometry has named Jocelyn Ou, OD, this year’s recipient of the Bert C. and Lydia M. Corwin Contact Lens Residency award. Dr. Ou is a cornea and contact lens resident at the Ketchum Health University Eye Center in Anaheim, California, and was ch
- Lineage Cell Therapeutics Launches New Corporate Brandhttps://modernod.com/news/lineage-cell-therapeutics-launches-new-corporate-brand/2479549/Lineage Cell Therapeutics, previously BioTime, announced the effective change of its corporate name and formal launch of its new corporate brand. In connection with the launch, the company’s NYSE American ticker symbol has changed to “LCTX” and will be effective at the open of t
- Regenxbio Reports Additional Positive Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-reports-additional-positive-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd/2476800/As part of its quarterly results reporting, Regenxbio provided an update on its phase 1/2a for RGX-314 for the treatment of wet AMD. “We are encouraged by the continued positive interim data from the phase 1/2a RGX-314 trial and the potential of NAV gene therapy as a one-time treatm